NTT Biopharma 奈力生醫

We provide the contract research services for novel formulation development, manufacturing process optimization, supply at the non-GMP quality level, and preliminary efficacy evaluation studies. Our aim is to develop nanomedicine products for therapies in diseases with complex drug delivery issues like brain cancer, immunotherapies, and ocular diseases. NTT Biopharma has its own pipeline of nano-formulated NCE/505(b)(2) products, and we also aim to partner with pharmaceutical companies seeking better solutions for drug delivery. NTT’s mission is to provide better solutions for drug delivery. We strive to develop safer, more convenient, and effective nano-pharmaceutical products to optimize therapies for various disease states. Mou is a professor in the Department of Chemistry at the National Taiwan University since 1982. Yen’s prior experiences include service as the Allen and Lee Chao Endowed Chair in Developmental Cancer Therapeutics at the City of Hope Comprehensive Cancer Center, and Chair of the City of Hope’s Molecular Pharmacology Department and Associate Director for Translational Research at the City of Hope Comprehensive Cancer Center. Our aim is to develop nanomedicine therapies for diseases with complex drug delivery issues like brain cancer, immunotherapies, and ocular diseases.